We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Woodford Patient Capital Trust Plc | LSE:WPCT | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 33.60 | 33.55 | 33.90 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSUPP
RNS Number : 9926L
Schroder UK Public Private Tst plc
16 September 2021
Schroder UK Public Private Trust plc (the "Company")
Oxford Nanopore Files Notice of Intention to Float
The Company (LSE: SUPP) is pleased to note that its portfolio company Oxford Nanopore Technologies Limited ("Oxford Nanopore") has today filed notice of its intention to float.
As part of the potential initial public offering ("IPO"), it is expected that the company will include a limited secondary offer. Final details on sizing will be made available when the final prospectus is published. While the Company remains highly confident of Oxford Nanopore's prospects to realise a strong IPO and generate continuous shareholder value, given the large position of Oxford Nanopore in the Company's portfolio (21.8% of its Net Asset Value as at 31 March 2021), the Company will seek to further diversify its portfolio through a partial realisation of its holding. The Company will use the proceeds from the partial realisation to invest in existing and new portfolio companies.
The Company's 3.7% stake in Oxford Nanopore was valued at GBP90.7 million as at 31 March 2021, an implied total equity value of GBP2.5bn. It is anticipated that the Company's AIFM will revalue the holding based on the trading price of Oxford Nanopore's shares, in line with the other quoted investments in the portfolio. The Company will release a further update once the pricing of Oxford Nanopore's IPO has been announced.
Enquiries:
Schroder Investment Management Limited
Gareth Faith Tel: 020 7658 5264
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ITFLFMPTMTMBMLB
(END) Dow Jones Newswires
September 16, 2021 04:13 ET (08:13 GMT)
1 Year Woodford Patient Capital Chart |
1 Month Woodford Patient Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions